RT Journal Article
SR Electronic
A1 Sylvester, Bruce
T1 Lessons from COURAGE
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 6
SP 30
OP 30
DO 10.1177/155989770800800619
UL http://mdc.sagepub.com/content/8/6/30.abstract
AB The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] trial evaluated percutaneous coronary intervention (PCI) as an initial management strategy in patients with stable coronary artery disease. Patients were randomly assigned to treatment with PCI in addition to medical therapy (n=1149) or medical therapy alone (n=1138). In the primary analysis, PCI did not reduce the risk of death or nonfatal myocardial infarction [Boden WE et al. N Engl J Med 2007].